eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | fibromyalgia |
| Comorbidity | C0041696|major depression |
| Sentences | 3 |
| PubMedID- 24504819 | Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. |
| PubMedID- 23506481 | While milnacipran was not studied in fibromyalgia patients with major depression, it may be a wise choice for fibromyalgia patients with depressive symptoms and patients for whom sedation, dizziness, edema or weight gain with gabapentin and pregabalin is a problem. |
| PubMedID- 21565595 | Conclusion: antidepressant treatment in fibromyalgia was effective in patients with and without major depression, but the functional response was greater in depressed patients. |
Page: 1